Circ_0003945: an emerging biomarker and therapeutic target for human diseases

Due to the rapid development of RNA sequencing techniques, a circular non-coding RNA (ncRNA) known as circular RNAs (circRNAs) has gradually come into focus. As a distinguished member of the circRNA family, circ_0003945 has garnered attention for its aberrant expression and biochemical functions in...

Full description

Bibliographic Details
Main Authors: Xiaofei Zhang, Li Ma, Li Wan, Haoran Wang, Zhaoxia Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1275009/full
_version_ 1797198710961078272
author Xiaofei Zhang
Li Ma
Li Wan
Haoran Wang
Zhaoxia Wang
author_facet Xiaofei Zhang
Li Ma
Li Wan
Haoran Wang
Zhaoxia Wang
author_sort Xiaofei Zhang
collection DOAJ
description Due to the rapid development of RNA sequencing techniques, a circular non-coding RNA (ncRNA) known as circular RNAs (circRNAs) has gradually come into focus. As a distinguished member of the circRNA family, circ_0003945 has garnered attention for its aberrant expression and biochemical functions in human diseases. Subsequent studies have revealed that circ_0003945 could regulate tumor cells proliferation, migration, invasion, apoptosis, autophagy, angiogenesis, drug resistance, and radio resistance through the molecular mechanism of competitive endogenous RNA (ceRNA) during tumorigenesis. The expression of circ_0003945 is frequently associated with some clinical parameters and implies a poorer prognosis in the majority of cancers. In non-malignant conditions, circ_0003945 also holds considerable importance in diseases pathogenesis. This review aims to recapitulate molecular mechanism of circ_0003945 and elucidates its potential as a diagnostic and therapeutic target in neoplasms and other diseases.
first_indexed 2024-04-24T07:04:12Z
format Article
id doaj.art-512dd08aaaf846aba31155f0f5cab0b6
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-24T07:04:12Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-512dd08aaaf846aba31155f0f5cab0b62024-04-22T05:09:23ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-04-011410.3389/fonc.2024.12750091275009Circ_0003945: an emerging biomarker and therapeutic target for human diseasesXiaofei Zhang0Li Ma1Li Wan2Haoran Wang3Zhaoxia Wang4Cancer Medical Center, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaCancer Medical Center, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Oncology, The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an, ChinaDivision of Spine Surgery, Department of Orthopedics, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaCancer Medical Center, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDue to the rapid development of RNA sequencing techniques, a circular non-coding RNA (ncRNA) known as circular RNAs (circRNAs) has gradually come into focus. As a distinguished member of the circRNA family, circ_0003945 has garnered attention for its aberrant expression and biochemical functions in human diseases. Subsequent studies have revealed that circ_0003945 could regulate tumor cells proliferation, migration, invasion, apoptosis, autophagy, angiogenesis, drug resistance, and radio resistance through the molecular mechanism of competitive endogenous RNA (ceRNA) during tumorigenesis. The expression of circ_0003945 is frequently associated with some clinical parameters and implies a poorer prognosis in the majority of cancers. In non-malignant conditions, circ_0003945 also holds considerable importance in diseases pathogenesis. This review aims to recapitulate molecular mechanism of circ_0003945 and elucidates its potential as a diagnostic and therapeutic target in neoplasms and other diseases.https://www.frontiersin.org/articles/10.3389/fonc.2024.1275009/fullcancercirc_0003945ceRNAbiomarkertherapeutic target
spellingShingle Xiaofei Zhang
Li Ma
Li Wan
Haoran Wang
Zhaoxia Wang
Circ_0003945: an emerging biomarker and therapeutic target for human diseases
Frontiers in Oncology
cancer
circ_0003945
ceRNA
biomarker
therapeutic target
title Circ_0003945: an emerging biomarker and therapeutic target for human diseases
title_full Circ_0003945: an emerging biomarker and therapeutic target for human diseases
title_fullStr Circ_0003945: an emerging biomarker and therapeutic target for human diseases
title_full_unstemmed Circ_0003945: an emerging biomarker and therapeutic target for human diseases
title_short Circ_0003945: an emerging biomarker and therapeutic target for human diseases
title_sort circ 0003945 an emerging biomarker and therapeutic target for human diseases
topic cancer
circ_0003945
ceRNA
biomarker
therapeutic target
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1275009/full
work_keys_str_mv AT xiaofeizhang circ0003945anemergingbiomarkerandtherapeutictargetforhumandiseases
AT lima circ0003945anemergingbiomarkerandtherapeutictargetforhumandiseases
AT liwan circ0003945anemergingbiomarkerandtherapeutictargetforhumandiseases
AT haoranwang circ0003945anemergingbiomarkerandtherapeutictargetforhumandiseases
AT zhaoxiawang circ0003945anemergingbiomarkerandtherapeutictargetforhumandiseases